简体中文 | 繁體中文 | English

Health and Pharmaceutical Press Releases

2018-10-11 10:18 New analysis estimates the positive impact of empagliflozin on prolonging life expectancy in adults with type 2 diabetes and established cardiovascular disease
2018-10-11 10:16 Oxford Nanopore Launches MinIT, a Powerful Analysis Device to Enable Real Time, Portable DNA Sequencing
2018-10-10 10:49 Brightree Launches BrightreeCARE App for Home Health and Hospice Aides
2018-10-09 18:01 Life Biosciences Acquires Lua, Pioneering AI-Driven Healthcare Platform
2018-10-09 15:54 STEPWORLD Co., Ltd. : Commencing Full-fledged Sales in China of "HELASLIM," a Tremendously Popular Supplement in Japan
2018-10-09 13:47 PharmAbcine Announces FDA Accepts IND Application of TTAC-0001 for the Treatment of Recurrent Glioblastoma
2018-10-09 10:37 Seattle Genetics and Takeda Announce Positive Results from Phase 3 ECHELON-2 Clinical Trial Evaluating ADCETRIS® (Brentuximab Vedotin) in Frontline CD30-Expressing Peripheral T-Cell Lymphoma
2018-10-09 09:40 Huntsman Cancer Institute at the University of Utah Selects Mevion to Provide Compact Single-Room System for the First Proton Therapy Center in Utah
2018-10-09 09:29 Celgene Announces Phase 3 STYLE Study of OTEZLA® (apremilast) in Moderate to Severe Scalp Psoriasis Met Primary Endpoint
2018-10-08 18:43 New Study Evaluates the Ability of Masimo ORi™ to Help Clinicians Reduce Hyperoxemia in Mechanically Ventilated ICU Patients
2018-10-08 14:14 Takeda Establishes Record Date for the Extraordinary General Meeting of Shareholders
2018-10-08 10:40 Boehringer Ingelheim and Lilly present full results of Trajenta®’s CARMELINA® cardiovascular outcome trial
2018-10-08 10:35 Boehringer Ingelheim and Lilly present full results from EASE Phase III programme for empagliflozin as adjunct to insulin in type 1 diabetes
2018-10-08 10:06 PMI Releases Position Paper for COP8: Addresses Need for Harm-Reduction Strategies
2018-10-08 09:38 Inter Partner Assistance Hong Kong Ltd. Forms a Partnership With The CareVoice To Provide Fully Digital Health Journeys and Integrated Healthcare Solutions to the Hong Kong Health Insurance Market
2018-09-27 17:59 Takeda to Present Positive Data from ALUNBRIG® (brigatinib) ALTA-1L Trial Showing a Reduction in Risk of Disease Progression or Death of More Than 50 Percent Versus Crizotinib in First-Line Advanced ALK+ NSCLC
2018-09-26 16:25 Global survey reveals that physicians need more information to assess the impact of treatment sequencing on patient survival in EGFR mutation-positive NSCLC
2018-09-26 14:31 Takeda Receives Positive CHMP Opinion Recommending ALUNBRIG® (brigatinib) for the Treatment of ALK+ Non-Small Cell Lung Cancer in Patients Previously Treated with Crizotinib
2018-09-26 09:52 PMI: Taking Bold Action for Global Change: a Conversation on Tobacco Today and Transformation for Tomorrow
2018-09-25 18:39 Emergent BioSolutions Expands Manufacturing Capability with ABEC Dual Purpose Single-Use Microbial Fermentation / Mammalian Cell Culture Systems

Business Wire Weibo

Press Releases

Latest Releases